Precision Oncology

Precision oncology is a new approach to cancer treatment, which utilizes the molecular profiling of each tumor to develop and tailor treatment strategies to each patient. The use of these biomarkers from tumors will help to predict those who will respond to specific treatments. Here is the latest research on precision oncology.

April 18, 2021
Review

Brain Metastases: An Update on Multi-disciplinary Approach of Clinical Management.

Neuro-Chirurgie
D MitchellM Dey
April 18, 2021
Review

Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Abedul HaqueArm R Amin
April 17, 2021
Preprint
Open Access

Copy-number intratumor heterogeneity contributes to predict relapse in chemotherapy-naive stage II colon cancer

BioRxiv : the Preprint Server for Biology
S. LahozJordi Camps
April 18, 2021

Comparison between MGI and Illumina sequencing platforms for whole genome sequencing.

Genes & Genomics
Sol A JeonSeon-Young Kim
April 18, 2021

Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.

Journal of Neuro-oncology
Yoon Ah ChoYeon-Lim Suh
April 18, 2021
Review

Precision oncology in metastatic colorectal cancer - from biology to medicine.

Nature Reviews. Clinical Oncology
Federica Di NicolantonioAlberto Bardelli
April 18, 2021
Open Access

Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16.

Scientific Reports
Stefania NobiliMarcella Coronnello
April 18, 2021
Open Access

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.

NPJ Breast Cancer
Edaise M da SilvaJorge S Reis-Filho
April 18, 2021

Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Anthony J YoungRobert K Doot
April 16, 2021

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.

Thyroid : Official Journal of the American Thyroid Association
Carrie Cunningham LubitzLori J Wirth
April 16, 2021
Open Access

Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo.

ACS Pharmacology & Translational Science
Ferah Comert OnderBulent Ozpolat
April 16, 2021
Open Access

Digital next-generation sequencing of cell-free DNA for pancreatic cancer.

JGH Open : an Open Access Journal of Gastroenterology and Hepatology
Shinichi TakanoNobuyuki Enomoto
April 16, 2021
Open Access

Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia.

JGH Open : an Open Access Journal of Gastroenterology and Hepatology
Keisuke TanakaNobuyuki Enomoto
April 16, 2021
Review
Open Access

Emerging and Experimental Agents for Anal Cancer: What is New?

Journal of Experimental Pharmacology
João Paulo F FariasAlexandre A Jácome
April 16, 2021
Open Access

Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients.

Scientific Reports
Divya BhagirathSharanjot Saini
April 16, 2021

Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential.

The American Journal of Dermatopathology
Kritika KrishnamurthyRobert Poppiti

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

© 2021 Meta ULC. All rights reserved
/feed-previews/precision-oncology/18be929d-593b-4a86-83de-155b6e8082c9